Premier Pharmacy Labs Inc. is recalling 1,610 syringes of Neostigmine Methylsulfate (1 mg per mL, 5 mg per 5 mL), a compounded injectable medication used in hospital and office settings. The recall was initiated because the product labels show a 'beyond use date' (expiration date) that is longer than what current stability data can support. This means the medication may lose its effectiveness or safety before the date printed on the label. These syringes were distributed to facilities in Florida, Maryland, Michigan, Minnesota, North Carolina, and Ohio.
Using medication past its true stability date can lead to reduced potency, meaning the drug may not work as intended to reverse the effects of certain muscle relaxants during surgery. While no injuries have been reported, an ineffective dose in a clinical setting could lead to inadequate recovery of muscle function.
Healthcare provider consultation and pharmacy return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.